-
Ehab B. replied to the topic "PM Problem Involving Pre-clinical Trial Results and Market Entry Deadlines" – 2 months, 4 weeks ago
@aca You raise an interesting issue here, as this is not just a technical setback but a design control and traceability event. With a high risk device like the stent, dissolution rate is not a secondary parameter, due to its… Read more»